DHAX-R regimen
WikiDoc Resources for DHAX-R regimen |
Articles |
---|
Most recent articles on DHAX-R regimen Most cited articles on DHAX-R regimen |
Media |
Powerpoint slides on DHAX-R regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on DHAX-R regimen at Clinical Trials.gov Trial results on DHAX-R regimen Clinical Trials on DHAX-R regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on DHAX-R regimen NICE Guidance on DHAX-R regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on DHAX-R regimen Discussion groups on DHAX-R regimen Patient Handouts on DHAX-R regimen Directions to Hospitals Treating DHAX-R regimen Risk calculators and risk factors for DHAX-R regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for DHAX-R regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:R-DHAX; rituximab/dexamethasone/cytarabine/oxaliplatin
Overview
DHAX-R regimen refers to a regimen consisting of dexamethasone, High dosecytarabine (Ara-C), oxaliplatin ,rituximab, used to treat relapsed/refractory B-cell non-Hodgkin lymphoma.[1]
Regimen
DDexamethasone
HHigh dose
Acytarabine (Ara-C)
xoxaliplatin
RRituximab
Indications
- Relapsed/refractory B-cell non-Hodgkin lymphoma[1]
- ↑ 1.0 1.1 Lignon J, Sibon D, Madelaine I, Brice P, Franchi P, Briere J; et al. (2010). "Rituximab, dexamethasone, cytarabine, and oxaliplatin (R-DHAX) is an effective and safe salvage regimen in relapsed/refractory B-cell non-Hodgkin lymphoma". Clin Lymphoma Myeloma Leuk. 10 (4): 262–9. doi:10.3816/CLML.2010.n.055. PMID 20709662.